New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 29, 2014
12:04 EDTDOW, DD, ALBChemical makers Dow, Albemarle rise after reporting results
Shares of two chemical makers, Dow Chemical (DOW) and Albemarle (ALB), are advancing after both companies reported stronger than expected results. DOW RESULTS: Dow Chemical reported its fourth quarter profits and revenue that both exceeded analysts' consensus estimates. The company stated that its volume had risen 2% last quarter versus the same period a year earlier, with volumes increasing in most of its operating segments and geographic areas. Overall demand was healthy last quarter and, as a result, Dow Chemical saw its margins on hydrocarbons increase, the company stated. The chemicals maker reported that the sales of all of its units except Feedstocks and Energy rose last quarter. Dow Chemical expects its earnings before interest, taxes, depreciation and amortization, or EBITDA, to rise to $10 billion in the near-term, up from $8.4 billion on an adjusted basis in 2013. Dow also increased its quarterly dividend by 15% to 37c per share and expanded its authorized share buy-back program to $4.5B from $1.5B. ALBEMARLE RESULTS: Similarly, Albemarle last night reported fourth quarter profits and revenue that surpassed analysts' consensus estimates. Moreover, the company's fiscal 2014 revenue guidance also exceeded analysts' consensus outlook. Albermarle stated that it had benefited from strong growth in its refinery catalyst and clean fuels technologies businesses. The company expects the profits from its catalyst business to increase by double digit percentage levels in 2014, and it expects its earnings from its clean fuels technologies to also rise. PRICE ACTION: In late morning trading, Dow Chemical climbed 3.7% to $44.67, while Albemarle advanced 2.3% to $64.65. Another chemicals maker, Du Pont, (DD) rose 2.85% to $61.27. Du Pont reported stronger than expected results yesterday morning and announced its own $5B share repurchase program.
News For DOW;ALB;DD From The Last 14 Days
Check below for free stories on DOW;ALB;DD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2014
12:53 EDTDDOn The Fly: Midday Wrap
Subscribe for More Information
09:55 EDTDDDuPont slips following results, levels to watch
Subscribe for More Information
09:29 EDTALBAlbemarle says sale of assets to SI Group was due to a need to consolidate
Subscribe for More Information
06:09 EDTDDDuPont reports adverse weather conditions reduced Q1 EPS by 7c
The company reports strong sales volume growth outside the Americas. Combined European and Asian developing markets volume up 10%; Europe, Middle East, & Africa volumes up 6%. Volume growth in the Americas constrained by shifts in timing and planted area in agriculture and the impact of harsh weather.
06:06 EDTDDDuPont backs FY14 operating EPS view of $4.20-$4.45, consensus $4.31
Subscribe for More Information
06:03 EDTDDDuPont reports Q1 EPS $1.58, consensus $1.58
Reports Q1 revenue $10.1B, consensus $10.45B. Ellen Kullman, DuPont Chair and CEO stated, "We delivered near record EPS despite the challenges of harsh weather and differences in year-on-year comparisons in our Agriculture Segment, and our key initiatives remain on track. I'm pleased with the progress we are making to deliver further value to shareholders and strengthen DuPont's position as an engine of science-driven innovation."
April 16, 2014
17:16 EDTALBAlbemarle reports Q1 adjusted EPS 96c, consensus 95c
Reports Q1 revenue $656.68M, consensus $655.87M.
16:05 EDTALBAlbemarle agrees to sell antioxidant, ibuprofen and propofol businesses
Albemarle Corporation announced that it has signed a definitive agreement to sell certain assets to SI Group. Included in the transaction are Albemarle's antioxidants and FDA-regulated ibuprofen and propofol businesses and assets, with manufacturing sites in Orangeburg, South Carolina and Jinshan, China; and Albemarle's antioxidant product lines. Certain applications and technical support capabilities in Shanghai, China and Baton Rouge, Louisiana will also be included in the transaction. Terms of the transaction, which is subject to customary closing conditions and is expected to close later in 2014, were not disclosed.
15:17 EDTDDNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include General Electric (GE), consensus 32c; Philip Morris (PM), consensus $1.16; Schlumberger (SLB), consensus $1.20; PepsiCo (PEP), consensus 75c; Union Pacific (UNP), consensus $2.37; UnitedHealth (UNH), consensus $1.09; Honeywell (HON), consensus $1.26; Goldman Sachs (GS), consensus $3.44; du Pont (DD), consensus $1.59; Morgan Stanley (MS), consensus 60c; Danaher (DHR), consensus 80c; BlackRock (BLK), consensus $4.14; Blackstone (BX), consensus 55c; Chipotle Mexican Grill (CMG), consensus $2.86; Mattel (MAT), consensus 9c; Snap-on (SNA), consensus $1.54; AutoNation (AN), consensus 74c.
April 9, 2014
12:04 EDTDDU.S. corn exports projected to increase 125M bushels
Subscribe for More Information
April 8, 2014
07:42 EDTDDSenate Agriculture, Nutrition & Forestry to hold a hearing
Subscribe for More Information
07:24 EDTDOWPR News to hold a conference
Subscribe for More Information
April 4, 2014
08:14 EDTDDDuPont, Tate & Lyle contemplating second biochemical plant, Bloomberg says
Subscribe for More Information
April 3, 2014
10:40 EDTDDDuPont $919M verdict thrown out by appeals court, Bloomberg reports
A U.S. court of appeals judge ruled that the trial judge in DuPontís victory over Kolon Industries for the alleged theft of trade secrets related to Kevlar had wrongly excluded evidence and the appeals court threw out the $919.9M court award for DuPont, according to Bloomberg. Reference Link
09:30 EDTDDApple, Pfizer others create 'go slow' patent lobby group, Reuters says
Subscribe for More Information
07:04 EDTDOWDow Chemical price target raised to $57 from $52 at UBS
UBS believes Dow Chemical's earnings are bottoming and that oil-based chemicals are near trough. The firm shifted its price target to 2015 estimates and raised it to $57 from $52 and maintains its Buy rating.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use